959149-71-4

Basic information

• Product Name: C₃₁H₃₉N₃O₅
• Synonyms: C₃₁H₃₉N₃O₅
• CAS NO: 959149-71-4
• Molecular Weight: 533.668
• Mol File: 959149-71-4.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: C₃₁H₃₉N₃O₅(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₁H₃₉N₃O₅(959149-71-4)
• EPA Substance Registry System: C₃₁H₃₉N₃O₅(959149-71-4)

Safety Data

• Hazardous Substances Data: 959149-71-4(Hazardous Substances Data)

Upstream product

• 488706-18-9 tris(methyloxycarbonylmethyl)methane 

Downstream Products

• 488706-20-3 1,1,1-tris[2-(p-methoxybenzylamino)ethyl]methane 

Relevant articles and documents

Diagnostic imaging agents with mmp inhibitory activity

The present invention relates to the field of diagnostic imaging. Specifically, the invention relates to the diagnostic imaging of diseases where specific matrix metalloproteinases are known to be involved. One embodiment of the invention is a compound having matrix metalloproteinase inhibitory activity suitable for diagnostic imaging. Also disclosed in the present invention is a pharmaceutical composition comprising the diagnostic imaging agent of the invention in a form suitable for mammalian administration. The invention furthermore discloses intermediates in the synthesis of the diagnostic imaging agents of the invention and kits for the preparation of the pharmaceutical composition of the invention. The pharmaceutical composition of the invention may be used in the diagnosis of diseases where specific matrix metalloproteinases are known to be involved.

NOVEL IMAGING AGENTS

The present invention relates to diagnostic imaging agents for in vivo imaging. The imaging agents comprise a synthetic caspase-3 inhibitor labelled with an imaging moiety suitable for diagnostic imaging in vivo. The invention also provides pharmaceutical